UPM Pharmaceuticals Revenue and Competitors

Bristol, TN USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • UPM Pharmaceuticals's estimated annual revenue is currently $40.8M per year.(i)
  • UPM Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • UPM Pharmaceuticals has 203 Employees.(i)
  • UPM Pharmaceuticals grew their employee count by 0% last year.

UPM Pharmaceuticals's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Quality AssuranceReveal Email/Phone
3
VP Research/DevelopmentReveal Email/Phone
4
VP / General CounselReveal Email/Phone
5
VP DistributionReveal Email/Phone
6
ControllerReveal Email/Phone
7
Director ManufacturingReveal Email/Phone
8
Director Project ManagementReveal Email/Phone
9
Director Product Development, R&DReveal Email/Phone
10
Associate Director, Inventory ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$145.5M5170%$28.5MN/A
#2
$102.7M5117%N/AN/A
#3
$58.7M2921%N/AN/A
#4
$8.2M41-2%N/AN/A
#5
$22.5M11212%$23.6MN/A
#6
$5.6M284%N/AN/A
#7
$11.3M568%N/AN/A
#8
$13.1M657%N/AN/A
#9
$7.6M3815%N/AN/A
#10
$7.2M363%N/AN/A
Add Company

What Is UPM Pharmaceuticals?

UPM Pharmaceuticals, Inc. is a Baltimore-based, independent drug development and contract manufacturer serving the pharmaceutical and biotechnology industries. Our scientists use state of the art technological approaches to solve challenging early stage pharmaceutical product design & formulation problems. We are characterized by the speed and thoroughness with which we complete difficult client engagements to formulate and manufacture drug products. Our clients enjoy service that is highly responsive and fast with total quality management characteristic of a customer focused business. With our commitment to flexibility and responsiveness, we deliver industry- savvy, customer focused drug development and contract drug manufacturing services. We enjoy successful collaborative interactions with leading pharmaceutical, biotechnology, and veterinary companies providing them with customized product development services and solutions. We specialize in products with oral routes of administration, including solids, semi-solids and oral liquids. These approaches control and improve the absorption of selected drugs in the bloodstream, improve dose reliability, reduce side effects and increase patient convenience and compliance.

keywords:N/A

N/A

Total Funding

203

Number of Employees

$40.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

UPM Pharmaceuticals News

2022-04-20 - GHS Labels Market Size Analysis By Growth, Emerging ...

... 2021-2030 | Avery Dennison, UPM Raflatac, PPG Industries ... fertilizers, and pharmaceuticals, the adoption & demand for GHS Labels is...

2022-04-17 - Waterproof Labels Market Segments and Forecast from 2022 ...

... Lintec Corporation, Bemis Company Inc, Upm Raflatac Ltd ... Pharmaceuticals, Cosmetics & Personal Care, Automotive, and Others...

2022-04-06 - Pharmaceutical Labels - Label and Narrow Web

The Covid-19 pandemic placed a greater emphasis on this vital labeling market, which continues to grow year-over-year. Pharmaceutical Labels. UPM Raflatac...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$55.2M20441%N/A
#2
$55.7M2069%N/A
#3
$48M2082%N/A
#4
$48.5M2103%N/A
#5
$65.9M2228%N/A